Goldman Sachs Group Inc Eye Point Pharmaceuticals, Inc. Transaction History

Goldman Sachs Group Inc

  • $555 Billion
  • Q1 2024

A detailed history of Goldman Sachs Group Inc transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 839,478 shares of EYPT stock, worth $7.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
839,478
Previous 567,986 47.8%
Holding current value
$7.3 Million
Previous $13.1 Million 32.2%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$19.93 - $29.71 $5.41 Million - $8.07 Million
271,492 Added 47.8%
839,478 $17.4 Million
Q4 2023

Feb 13, 2024
SELL
$5.71 - $24.13 $185,506 - $783,935
-32,488 Reduced 5.41%
567,986 $13.1 Million
Q3 2023

May 14, 2024
BUY
$7.99 - $15.36 $259,579 - $499,015
32,488 Added 5.72%
600,474 $4.8 Million
Q3 2023

Nov 14, 2023
BUY
$7.99 - $15.36 $1.39 Million - $2.66 Million
173,423 Added 40.61%
600,474 $4.8 Million
Q2 2023

May 14, 2024
SELL
$3.03 - $9.0 $834,858 - $2.48 Million
-275,531 Reduced 39.22%
427,051 $3.72 Million
Q2 2023

Aug 14, 2023
SELL
$3.03 - $9.0 $834,858 - $2.48 Million
-275,531 Reduced 39.22%
427,051 $3.72 Million
Q1 2023

May 14, 2024
SELL
$2.28 - $5.04 $137,271 - $303,443
-60,207 Reduced 7.89%
702,582 $2.07 Million
Q1 2023

May 11, 2023
SELL
$2.28 - $5.04 $137,271 - $303,443
-60,207 Reduced 7.89%
702,582 $2.07 Million
Q4 2022

May 14, 2024
SELL
$2.37 - $7.2 $213,100 - $647,395
-89,916 Reduced 10.54%
762,789 $2.67 Million
Q4 2022

Feb 13, 2023
SELL
$2.37 - $7.2 $213,100 - $647,395
-89,916 Reduced 10.54%
762,789 $2.67 Million
Q3 2022

May 14, 2024
SELL
$6.96 - $11.12 $243,091 - $388,388
-34,927 Reduced 3.93%
852,705 $6.75 Million
Q3 2022

Nov 10, 2022
SELL
$6.96 - $11.12 $243,091 - $388,388
-34,927 Reduced 3.93%
852,705 $6.74 Million
Q2 2022

May 14, 2024
BUY
$7.25 - $12.71 $2.32 Million - $4.06 Million
319,646 Added 56.28%
887,632 $6.99 Million
Q2 2022

Aug 15, 2022
BUY
$7.25 - $12.71 $119,849 - $210,109
16,531 Added 1.9%
887,632 $6.99 Million
Q1 2022

May 16, 2022
BUY
$8.67 - $14.11 $2.16 Million - $3.51 Million
249,083 Added 40.04%
871,101 $10.6 Million
Q4 2021

Feb 14, 2022
BUY
$10.18 - $18.4 $5.93 Million - $10.7 Million
582,925 Added 1491.12%
622,018 $7.61 Million
Q3 2021

Nov 10, 2021
BUY
$7.51 - $11.72 $293,588 - $458,169
39,093 New
39,093 $407,000

Others Institutions Holding EYPT

# of Institutions
176
Shares Held
53.9M
Call Options Held
764K
Put Options Held
1.57M
View Full List

About EyePoint Pharmaceuticals, Inc.

EYPT Quotes by TradingView
  • Ticker EYPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,072,200
  • Market Cap $296M
  • Description
  • EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...
More about EYPT
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email